s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
424B3
Prospectus filed pursuant to Rule 424(b)(3)
Filed
Wednesday, June 18, 2025
Accession number
0001641172-25-015608
Documents
Prospectus filed pursuant to Rule 424(b)(3)
424B3
On sec.gov
Filing index
All files
Complete submission text
SGML header